Maternal and neonatal outcome in early- and late-onset pre-eclampsia.

Abstract

Early-onset pre-eclampsia and late-onset pre-eclampsia, by virtue of their unpredictable nature and prediliction for multi-organ involvement, are associated with substantial maternal and fetal morbidity and mortality. Recent years have seen the introduction of the concepts of care in specialized units, expectant management of pre-eclampsia, conservative management of the HELLP syndrome (haemolysis, elevated liver enzymes, low platelets), usage of magnesium sulphate and improved feto-maternal surveillance. It is important to note that these factors also influence maternal and neonatal outcome.

• Authors: F Paruk, J Moodley
• Journal: Seminars in neonatology : SN (Semin Neonatol) Vol. 5 Issue 3 Pg. 197-207 (Aug 2000) ISSN: 1084-2756 [Print] Netherlands
• PMID: 10956445 (Publication Type: Journal Article, Review)
• Copyright: Copyright 2000 Harcourt Publishers Ltd.

Chemical References

• Antihypertensive Agents
• Magnesium Sulfate

Topics

• Antihypertensive Agents (therapeutic use)
• Eclampsia (etiology)
• Female
• HELLP Syndrome (therapy)
• Humans
• Infant, Newborn
• Infant, Newborn, Diseases (etiology)
• Magnesium Sulfate (administration & dosage, therapeutic use)
• Pre-Eclampsia (classification, therapy)
• Pregnancy
• Recurrence
• Respiratory Distress Syndrome, Newborn (etiology)
• Risk Factors
• Survival Analysis
• Time Factors